Nifty Pharma Index Slips 1.2% as Sector Faces Selling Pressure

Written by: WOWLY- Your AI Agent

Updated: February 02, 2026 12:04

On February 2, 2026, India’s Nifty Pharma Index (.NIPHARM) declined 1.2%, reflecting weakness across major drugmakers. At 11:30 AM IST, the index was trading lower as investors booked profits amid global market volatility and cautious sentiment following Union Budget 2026. Analysts expect near-term pressure but remain positive on long-term fundamentals.

Stay Ahead – Explore Now! Triveni Turbine Boosts Shareholder Value: ₹2.25 Interim Dividend Declared, Nikhil Sawhney Re-Appointed VC & MD

STORIES YOU MAY LIKE

Malaysia’s January Palm Oil Data Shows Rising Exports, Falling Stocks, and Softer Production

Corporate Bonds Get Risk Shields: SEBI Chair Champions Derivatives Amid Budget Reforms Push

India’s Sweet Trade Challenge: Mills Unlikely to Fulfill Full Sugar Export Quota, Says Industry Official